Rapid Micro Biosystems Reports Q2 2026 Financial Results

What Happened
Rapid Micro Biosystems, Inc. announced its financial results for the quarter ended June 30, 2026 by issuing a press release on August 7, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8‑K (Item 2.02), which was signed by Chief Financial Officer Sean Wirtjes and filed the same day.

Key Details

• Filed Form 8‑K on August 7, 2026 reporting results for the quarter ended June 30, 2026 (Item 2.02).
• Press release announcing the quarterly results is attached as Exhibit 99.1 to the 8‑K.
• Exhibit index also includes the Cover Page Interactive Data File (inline XBRL) as Exhibit 104 (Item 9.01).
• Form 8‑K was signed by Sean Wirtjes, Chief Financial Officer.

Why It Matters
This filing provides the company’s official disclosure of its latest quarterly earnings and financial condition—information investors use to assess recent revenue, profitability, and short‑term trends. The attached press release is the primary source for the specific figures (revenue, net income/loss, guidance, or commentary); investors should read Exhibit 99.1 for detailed quarterly results and any management commentary that could affect valuation or near‑term trading.